Khan, Khurum H
68  results:
Search for persons X
?
3

Cancer therapeutics: Targeting the apoptotic pathway:

Khan, Khurum H. ; Blanco-Codesido, Montserrat ; Molife, L. Rhoda
Critical Reviews in Oncology/Hematology.  90 (2014)  3 - p. 200-219 , 2014
 
?
4

Targeting the PI3K-AKT-mTOR signaling network in cancer:

Khan, Khurum H. ; Yap, Timothy A. ; Yan, Li.
Chinese Journal of Cancer.  32 (2013)  5 - p. 253-265 , 2013
 
?
9

Targeting the PI3K-AKT-mTOR signaling network in cancer:

Khan, Khurum H ; Yap, Timothy A ; Yan, Li.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845556.  , 2013
 
?
12

Neoadjuvant FOLFIRINOX in Patients With Borderline Resectab..:

Janssen, Quisette P ; Buettner, Stefan ; Suker, Mustafa...
JNCI: Journal of the National Cancer Institute.  111 (2019)  8 - p. 782-794 , 2019
 
?
13

Establishment of CORONET, COVID-19 Risk in Oncology Evaluat..:

Lee, Rebecca J ; Wysocki, Oskar ; Zhou, Cong...
info:eu-repo/semantics/altIdentifier/doi/10.1200/CCI.21.00177.  , 2022
 
?
14

Establishment of CORONET, COVID-19 Risk in Oncology Evaluat..:

Lee, Rebecca J ; Wysocki, Oskar ; Zhou, Cong...
info:eu-repo/semantics/altIdentifier/doi/10.1200/CCI.21.00177.  , 2022
 
?
15

Establishment of CORONET, COVID-19 Risk in Oncology Evaluat..:

Lee, Rebecca J ; Wysocki, Oskar ; Zhou, Cong...
info:eu-repo/semantics/altIdentifier/doi/10.1200/CCI.21.00177.  , 2022
 
1-15